Apyx Medical Corporation (APYX) Financial Statements (2024 and earlier)

Company Profile

Business Address 5115 ULMERTON ROAD
CLEARWATER, FL 33760
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,19230,87041,91558,81278,1449,949
Cash and cash equivalents10,19230,87041,91558,81216,4669,949
Short-term investments     61,678 
Receivables18,24621,16317,3289,2205,0154,857
Inventory, net of allowances, customer advances and progress billings11,7976,7784,0515,0685,2126,526
Inventory11,7976,7784,0515,0685,2126,526
Contract with customer, asset, after allowance for credit loss 100100   
Other undisclosed current assets2,6371,8262,7953,6331,1461,215
Total current assets:42,97260,73766,08976,73389,51722,547
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization115178437653
Operating lease, right-of-use asset710121237350
Property, plant and equipment6,7616,5756,5416,6185,7886,408
Intangible assets, net (including goodwill)     1911,874
Goodwill     185185
Intangible assets, net (excluding goodwill)     61,689
Deposits noncurrent assets     7392
Other noncurrent assets1,2171,1108073914167
Total noncurrent assets:8,8037,9848,0228,0126,0938,441
TOTAL ASSETS:51,77568,72174,11184,74595,61030,988
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,59712,9188,78911,8345,3184,492
Employee-related liabilities   1,390521
Accounts payable2,6692,6311,5112,4381,4231,583
Accrued liabilities8,92810,2877,2789,3962,5052,388
Debt37165238337 239
Due to related parties   140  
Other undisclosed current liabilities216122126 2,3841,242
Total current liabilities:11,85013,2059,15312,3117,7025,973
Noncurrent Liabilities
Long-term debt and lease obligation73183126561402,455
Long-term debt, excluding current maturities    1402,455
Finance lease, liability7318183421
Liabilities, other than long-term debt2,0591,489787519 20
Deferred revenue1,4081,323621 
Other liabilities181166166519  
Operating lease, liability470 129235
Derivative instruments and hedges, liabilities      20
Other undisclosed noncurrent liabilities      508
Total noncurrent liabilities:2,1321,5071,0991,1751402,983
Total liabilities:13,98214,71210,25213,4867,8428,956
Equity
Equity, attributable to parent37,58253,70463,72171,25987,76822,032
Common stock353434343433
Additional paid in capital73,28266,22161,06656,70852,22150,495
Retained earnings (accumulated deficit)(35,735)(12,551)2,62114,51735,513(28,496)
Equity, attributable to noncontrolling interest211305138   
Total equity:37,79354,00963,85971,25987,76822,032
TOTAL LIABILITIES AND EQUITY:51,77568,72174,11184,74595,61030,988

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues44,51048,51727,71128,23516,68638,883
Revenue, net16,68638,883
Cost of revenue
(Cost of Goods and Services Sold)
(15,379)(14,916)(10,207)(9,141)(5,893)(19,122)
Gross profit:29,13133,60117,50419,09410,79319,761
Operating expenses(52,693)(48,049)(37,587)(39,963)(24,393)(25,026)
Other operating expense, net    (203) 
Other undisclosed operating income    203 
Operating loss:(23,562)(14,448)(20,083)(20,869)(13,600)(5,265)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
651(372)6741,03332947
Interest and debt expense(15)(10)(46)(8)(104) 
Loss from continuing operations before equity method investments, income taxes:(22,926)(14,830)(19,455)(19,844)(13,375)(5,218)
Other undisclosed income from continuing operations before income taxes1510468104 
Loss from continuing operations before income taxes:(22,911)(14,820)(19,409)(19,836)(13,271)(5,218)
Income tax expense (benefit)(367)(380)7,5031303,777156
Loss from continuing operations:(23,278)(15,200)(11,906)(19,706)(9,494)(5,062)
Loss before gain (loss) on sale of properties:(15,200)(11,906)(19,706)(9,494)(5,062)
Net loss:(23,278)(15,200)(11,906)(19,706)(9,494)(5,062)
Net income attributable to noncontrolling interest942810   
Net loss attributable to parent:(23,184)(15,172)(11,896)(19,706)(9,494)(5,062)
Other undisclosed net income available to common stockholders, basic     73,503 
Net income (loss) available to common stockholders, basic:(23,184)(15,172)(11,896)(19,706)64,009(5,062)
Other undisclosed net loss available to common stockholders, diluted      (183)
Net income (loss) available to common stockholders, diluted:(23,184)(15,172)(11,896)(19,706)64,009(5,245)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(23,278)(15,200)(11,906)(19,706)(9,494)(5,062)
Comprehensive loss:(23,278)(15,200)(11,906)(19,706)(9,494)(5,062)
Comprehensive income, net of tax, attributable to noncontrolling interest942810   
Comprehensive loss, net of tax, attributable to parent:(23,184)(15,172)(11,896)(19,706)(9,494)(5,062)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: